Invention Grant
- Patent Title: Quality assurance of chondrocytes
-
Application No.: US16387172Application Date: 2019-04-17
-
Publication No.: US10781424B2Publication Date: 2020-09-22
- Inventor: Evy Lundgren Åkerlund , Katarzyna Chmielarska Masoumi
- Applicant: Xintela AB
- Applicant Address: SE Lund
- Assignee: Xintela AB
- Current Assignee: Xintela AB
- Current Assignee Address: SE Lund
- Agency: McNeill Baur PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3bab17aa
- Main IPC: C12N5/077
- IPC: C12N5/077 ; C12N5/00 ; C12Q1/6851 ; G01N33/68
Abstract:
The present invention relates to methods that are based on expression of integrin alpha10 and integrin alpha11 on chondrocytes, used for determining purity, quality, degree of chondrocytic identity, chondrocytic potency, and/or degree of chondrocytic phenotype of a composition comprising chondrocytes, as well as for isolating and enriching a population of high quality chondrocytes and controlling culturing and expanding of high quality chondrocytes. The present invention relates also to composition comprising chondrocytes.
Public/Granted literature
- US20190300855A1 Quality Assurance of Chondrocytes Public/Granted day:2019-10-03
Information query
